Vanguard Group’s PMV Pharmaceuticals PMVP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.28M | Sell |
2,153,600
-21,461
| -1% | -$22.7K | ﹤0.01% | 3497 |
|
|
2025
Q1 | $2.37M | Buy |
2,175,061
+31,959
| +1% | +$34.8K | ﹤0.01% | 3443 |
|
|
2024
Q4 | $3.24M | Sell |
2,143,102
-137,701
| -6% | -$208K | ﹤0.01% | 3421 |
|
|
2024
Q3 | $3.4M | Sell |
2,280,803
-1,287
| -0.1% | -$1.92K | ﹤0.01% | 3403 |
|
|
2024
Q2 | $3.7M | Sell |
2,282,090
-170,021
| -7% | -$275K | ﹤0.01% | 3377 |
|
|
2024
Q1 | $4.17M | Buy |
2,452,111
+46,804
| +2% | +$79.6K | ﹤0.01% | 3372 |
|
|
2023
Q4 | $7.46M | Buy |
2,405,307
+362,986
| +18% | +$1.13M | ﹤0.01% | 3113 |
|
|
2023
Q3 | $12.5M | Buy |
2,042,321
+7,288
| +0.4% | +$44.7K | ﹤0.01% | 2753 |
|
|
2023
Q2 | $12.7M | Buy |
2,035,033
+71,613
| +4% | +$448K | ﹤0.01% | 2810 |
|
|
2023
Q1 | $9.37M | Sell |
1,963,420
-790,186
| -29% | -$3.77M | ﹤0.01% | 2972 |
|
|
2022
Q4 | $24M | Sell |
2,753,606
-680,359
| -20% | -$5.92M | ﹤0.01% | 2537 |
|
|
2022
Q3 | $40.9M | Buy |
3,433,965
+78,001
| +2% | +$928K | ﹤0.01% | 2279 |
|
|
2022
Q2 | $47.8M | Buy |
3,355,964
+617,081
| +23% | +$8.79M | ﹤0.01% | 2213 |
|
|
2022
Q1 | $57M | Buy |
2,738,883
+90,937
| +3% | +$1.89M | ﹤0.01% | 2238 |
|
|
2021
Q4 | $61.2M | Sell |
2,647,946
-5,448
| -0.2% | -$126K | ﹤0.01% | 2239 |
|
|
2021
Q3 | $79.1M | Buy |
2,653,394
+411,683
| +18% | +$12.3M | ﹤0.01% | 2110 |
|
|
2021
Q2 | $76.6M | Buy |
2,241,711
+1,054,433
| +89% | +$36M | ﹤0.01% | 2140 |
|
|
2021
Q1 | $39.1M | Buy |
1,187,278
+28,771
| +2% | +$946K | ﹤0.01% | 2444 |
|
|
2020
Q4 | $71.3M | Buy |
1,158,507
+1,138,507
| +5,693% | +$70M | ﹤0.01% | 2019 |
|
|
2020
Q3 | $710K | Buy |
+20,000
| New | +$710K | ﹤0.01% | 3743 |
|